Gynecologic Malignancies in Children and Adolescents: How Common is the Uncommon?

The aim of this study is to assess the projected incidence and prognostic indicators of gynecologic malignancies in the pediatric population. In this population-based retrospective cohort study, girls ≤18 years with ovarian, uterine, cervical, vaginal and vulvar malignancies diagnosed between 2000 a...

Full description

Bibliographic Details
Main Authors: Christoph Wohlmuth, Iris Wohlmuth-Wieser
Format: Article
Language:English
Published: MDPI AG 2021-02-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/10/4/722
_version_ 1797396790903832576
author Christoph Wohlmuth
Iris Wohlmuth-Wieser
author_facet Christoph Wohlmuth
Iris Wohlmuth-Wieser
author_sort Christoph Wohlmuth
collection DOAJ
description The aim of this study is to assess the projected incidence and prognostic indicators of gynecologic malignancies in the pediatric population. In this population-based retrospective cohort study, girls ≤18 years with ovarian, uterine, cervical, vaginal and vulvar malignancies diagnosed between 2000 and 2016 were identified from the Surveillance, Epidemiology and End Results (SEER)-18 registry. The Kaplan–Meier method was used to analyze overall survival (OS). The age-adjusted annual incidence of gynecologic malignancies was 6.7 per 1,000,000 females, with neoplasms of the ovary accounting for 87.5%, vagina 4.5%, cervix 3.9%, uterus 2.5% and vulva 1.6% of all gynecologic malignancies. Malignant germ-cell tumors represented the most common ovarian neoplasm, with an increased incidence in children from 5–18 years. Although certain subtypes were associated with advanced disease stages, the 10-year OS rate was 96.0%. Sarcomas accounted for the majority of vaginal, cervical, uterine and vulvar malignancies. The majority of vaginal neoplasms were observed in girls between 0–4 years, and the 10-year OS rate was 86.1%. Overall, gynecologic malignancies accounted for 4.2% of all malignancies in girls aged 0–18 years and the histologic subtypes and prognosis differed significantly from patients in older age groups.
first_indexed 2024-03-09T00:56:38Z
format Article
id doaj.art-76ce937a719343618af12d5eb5759ed2
institution Directory Open Access Journal
issn 2077-0383
language English
last_indexed 2024-03-09T00:56:38Z
publishDate 2021-02-01
publisher MDPI AG
record_format Article
series Journal of Clinical Medicine
spelling doaj.art-76ce937a719343618af12d5eb5759ed22023-12-11T16:50:15ZengMDPI AGJournal of Clinical Medicine2077-03832021-02-0110472210.3390/jcm10040722Gynecologic Malignancies in Children and Adolescents: How Common is the Uncommon?Christoph Wohlmuth0Iris Wohlmuth-Wieser1Department of Obstetrics and Gynecology, Paracelsus Medical University Salzburg, 5020 Salzburg, AustriaDepartment of Dermatology, Paracelsus Medical University Salzburg, 5020 Salzburg, AustriaThe aim of this study is to assess the projected incidence and prognostic indicators of gynecologic malignancies in the pediatric population. In this population-based retrospective cohort study, girls ≤18 years with ovarian, uterine, cervical, vaginal and vulvar malignancies diagnosed between 2000 and 2016 were identified from the Surveillance, Epidemiology and End Results (SEER)-18 registry. The Kaplan–Meier method was used to analyze overall survival (OS). The age-adjusted annual incidence of gynecologic malignancies was 6.7 per 1,000,000 females, with neoplasms of the ovary accounting for 87.5%, vagina 4.5%, cervix 3.9%, uterus 2.5% and vulva 1.6% of all gynecologic malignancies. Malignant germ-cell tumors represented the most common ovarian neoplasm, with an increased incidence in children from 5–18 years. Although certain subtypes were associated with advanced disease stages, the 10-year OS rate was 96.0%. Sarcomas accounted for the majority of vaginal, cervical, uterine and vulvar malignancies. The majority of vaginal neoplasms were observed in girls between 0–4 years, and the 10-year OS rate was 86.1%. Overall, gynecologic malignancies accounted for 4.2% of all malignancies in girls aged 0–18 years and the histologic subtypes and prognosis differed significantly from patients in older age groups.https://www.mdpi.com/2077-0383/10/4/722gynecologic malignanciespediatric cancergynecologic cancerpediatricadolescentfemale
spellingShingle Christoph Wohlmuth
Iris Wohlmuth-Wieser
Gynecologic Malignancies in Children and Adolescents: How Common is the Uncommon?
Journal of Clinical Medicine
gynecologic malignancies
pediatric cancer
gynecologic cancer
pediatric
adolescent
female
title Gynecologic Malignancies in Children and Adolescents: How Common is the Uncommon?
title_full Gynecologic Malignancies in Children and Adolescents: How Common is the Uncommon?
title_fullStr Gynecologic Malignancies in Children and Adolescents: How Common is the Uncommon?
title_full_unstemmed Gynecologic Malignancies in Children and Adolescents: How Common is the Uncommon?
title_short Gynecologic Malignancies in Children and Adolescents: How Common is the Uncommon?
title_sort gynecologic malignancies in children and adolescents how common is the uncommon
topic gynecologic malignancies
pediatric cancer
gynecologic cancer
pediatric
adolescent
female
url https://www.mdpi.com/2077-0383/10/4/722
work_keys_str_mv AT christophwohlmuth gynecologicmalignanciesinchildrenandadolescentshowcommonistheuncommon
AT iriswohlmuthwieser gynecologicmalignanciesinchildrenandadolescentshowcommonistheuncommon